Aarti Drugs Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)
Aarti Drugs Ltd · Financial Result · 04 Nov 2026, 12:33 am
Aarti Drugs Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 82,624 (+26.6% YoY | +17.6% QoQ) ■ EBITDA: 13,536 (+60.6% YoY | +37.9% QoQ) ■ EBITDA Margin (%): 16.4 (+347 bps YoY | +241 bps QoQ) ■ PAT: 8,294 (+83.2% YoY | +65.3% QoQ) ■ EPS (INR): 9.07 (+83.2% YoY | +65.2% QoQ)
Original exchange filing (PDF)
More announcements from Aarti Drugs Ltd
- Intimation of sad demise of Promoter and Chairman Emeritus of the Company · 16 Nov 2026
- Transcript of Q2&H1 FY27 Earning Conference call · 11 Nov 2026
- Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requireents) Regulations, 2015 · 06 Nov 2026
- Audio recording for conference call for Analyst and Investors · 05 Nov 2026
- Investor Presentation for Q2 FY27 · 04 Nov 2026
- Press release on Financial results for Quarter and Half year ended September 2026 · 04 Nov 2026
- Financial Results for the quarter and half year ended September 30, 2026 · 04 Nov 2026
- Aarti Drugs Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 04 Nov 2026
